Incidence of Cardiovascular Diseases in Patients With Hypopituitarims

The aim of the present study was therefore two-fold: 1) to make a retrospective comparison of incidence of non-fatal stroke and cardiac events between a large cohort of patients with confirmed GHD on replacement therapy (including GH) and a control cohort from the general population; 2) to compare the prevalence of DM and cardioprotective medication between the cohorts at the time of questionnaire distribution with adjustment for possible confounders and effect modifiers.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiovascular Diseases Bone Diseases Bone Diseases, Developmental Bone Diseases, Endocrine Brain Diseases Central Nervous System Diseases Cerebrovascular Disorders Diabetes Mellitus Dwarfism Dwarfism, Pituitary Endocrine System Diseases Glucose Metabolism Disorders Heart Diseases Hypertension Hypopituitarism Hypothalamic Diseases Metabolic Diseases Musculoskeletal Diseases Nervous System Diseases Nutritional and Metabolic Diseases Pituitary Diseases Vascular Diseases

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Confirmed GH deficiency

Exclusion criteria

Not confirmed GH deficiency

Sponsors and collaborators

Lead sponsor

Lund University Hospital

Other

Registry information

Important dates

Study start: 1999
Study completion: 2002
First posted: Mar 5, 2007
Registry last updated: Mar 5, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed